Emergent CEO Remarks from Q1’21 Earnings
Thank you, Bob, and good afternoon to everyone. Thank you for joining us. As you know, we have been in the news lately primarily related to our COVID-19 manufacturing activities. As a result and...
Emergent BioSolutions launched a new television and digital ad as part of its “We Go” campaign
Today, Emergent BioSolutions launched a new television and digital ad as part of its “We Go” campaign that launched last May, sharing the company’s commitment to fighting the COVID-19 pandemic....
Emergent BioSolutions Statement on Status of Current Manufacturing of COVID-19 Vaccines at Company’s Baltimore Bayview Facility
GAITHERSBURG, Md., April 01, 2021 – At Emergent (NYSE: EBS), safety and quality are our top priorities. Our Bayview facility has been designed and validated to meet all current Good Manufacturing...
Emergent BioSolutions Statement on Johnson & Johnson’s Collaboration with Merck
GAITHERSBURG, Md. March 03, 2021 – Emergent BioSolutions welcomes the addition of Merck & Co’s capabilities to the fight against COVID-19, a move that will add to existing supply and help...